| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.29 | 7e-10 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.17 | 0.0009 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.084 | 0.07 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.077 | 0.1 |